Regulus Therapeutics Reports First Quarter 2023 Financial Results and Recent Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/29/2026

1. V
2. PYPL
3. KLAC
4. F
5. STX
6. BE
7. SWKS
8. CSGP
9. VRNS
10. NXPI

Go back to Regulus Therapeutics Reports First Quarter 2023 Financial Results and Recent Updates

Regulus Therapeutics (RGLS) Tops Q1 EPS by 3c

May 11, 2023 4:50 PM EDT

Regulus Therapeutics (NASDAQ: RGLS) reported Q1 EPS of ($0.42), $0.03 better than the analyst estimate of ($0.45).

For earnings history and earnings-related data on Regulus Therapeutics (RGLS) click here.

... More